SEC Tracker
Get the app
Person · CIK 1956241

Konstantinos Xynos

Chief Medical Officer at Replimune Group

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$682K
Noticed on Form 144$119K
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Replimune Group REPLCommon StockDirectly224,215Aug 10, 2026 · Filing · EDGAR
Replimune Group REPLEmployee Stock Option (right to buy)
exercise $7.61, expires Apr 1, 2036, into Common Stock
Directly75,000Apr 1, 2026 · Filing · EDGAR

Sold and noticed by quarter

Konstantinos Xynos: dollars sold on Form 4 and noticed on Form 144 per quarter, Q2 2023 to Q4 2026$160K$0Q2 2023: $0 noticed on Form 144Q2 2023: $14K sold on Form 4Q3 2023: $0 noticed on Form 144Q3 2023: $0 sold on Form 4Q4 2023: $0 noticed on Form 144Q4 2023: $80K sold on Form 4Q1 2024: $0 noticed on Form 144Q1 2024: $0 sold on Form 4Q2 2024: $119K noticed on Form 144Q2 2024: $160K sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $0 sold on Form 4Q4 2024: $0 noticed on Form 144Q4 2024: $78K sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $64K sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $66K sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $0 sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $71K sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $148K sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q2 2023Q1 2024Q4 2024Q3 2025Q2 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q3 2026$148K—
Q2 2026$71K—
Q4 2025$66K—
Q2 2025$64K—
Q4 2024$78K—
Q2 2024$160K$119K
Q4 2023$80K—
Q2 2023$14K—

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Replimune Group REPL · J.P. Morgan Securities · 10b5-1 plan adopted Feb 13, 2024 · 1 notice
Jun 7, 202415,881 · ~$119KJun 7, 2024Sold as noticed Sold 15,881 at $7.50 on Jun 7 · $119K Form 4Filing · EDGAR
Sales without a matching Form 144 · 8 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Replimune Group (REPL): Sold 11,447 at $12.97 on Aug 10, 2026 · $148KFiling · EDGAR
———Sold without notice Replimune Group (REPL): Sold 14,023 at $5.08 on May 18, 2026 · $71KFiling · EDGAR
———Sold without notice Replimune Group (REPL): Sold 7,248 at $9.10 on Nov 17, 2025 · $66KFiling · EDGAR
———Sold without notice Replimune Group (REPL): Sold 7,952 at $8.06 on May 20, 2025 · $64KFiling · EDGAR
———Sold without notice Replimune Group (REPL): Sold 7,246 at $10.78 on Nov 18, 2024 · $78KFiling · EDGAR
———Sold without notice Replimune Group (REPL): Sold 6,367 at $6.47 on May 16, 2024 · $41KFiling · EDGAR
———Sold without notice Replimune Group (REPL): Sold 7,313 at $10.92 on Nov 16, 2023 · $80KFiling · EDGAR
———Sold without notice Replimune Group (REPL): Sold 771 at $18.05 on May 16, 2023 · $14KFiling · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Replimune Group REPL Chief Medical Officer · filings 2022 to 2026 · sold $682K · $119K noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Aug 10, 2026Open-market or private sale−11,447$12.97$148K224,215 directFiling · EDGAR
May 18, 2026Open-market or private sale−14,023$5.08$71K235,662 directFiling · EDGAR
Apr 1, 2026Grant or award from the company+50,000249,685 directFiling · EDGAR
Apr 1, 2026Grant or award from the company
Employee Stock Option (right to buy)
+75,00075,000 directFiling · EDGAR
Dec 19, 2025Grant or award from the company+60,000199,685 directFiling · EDGAR
Nov 17, 2025Open-market or private sale−7,248$9.10$66K139,685 directFiling · EDGAR
May 20, 2025Open-market or private sale−7,952$8.06$64K146,933 directFiling · EDGAR
Apr 1, 2025Grant or award from the company+45,000154,885 directFiling · EDGAR
Apr 1, 2025Grant or award from the company
Employee Stock Option (right to buy)
+67,50067,500 directFiling · EDGAR
Nov 18, 2024Open-market or private sale−7,246$10.78$78K109,885 directFiling · EDGAR
Jun 7, 2024Sale under a 10b5-1 plan−15,881$7.50$119K117,131 directFiling · EDGAR
May 16, 2024Open-market or private sale−6,367$6.47$41K133,012 directFiling · EDGAR
Apr 1, 2024Grant or award from the company+26,665139,379 directFiling · EDGAR
Apr 1, 2024Grant or award from the company
Employee Stock Option (right to buy)
+80,00080,000 directFiling · EDGAR
Nov 16, 2023Open-market or private sale−7,313$10.92$80K112,714 directFiling · EDGAR
May 16, 2023Open-market or private sale−771$18.05$14K120,027 directFiling · EDGAR
Apr 1, 2023Grant or award from the company+50,000120,798 directFiling · EDGAR
Apr 1, 2023Grant or award from the company
Employee Stock Option (right to buy)
+75,00075,000 directFiling · EDGAR
Dec 1, 2022Grant or award from the company+17,50070,798 directFiling · EDGAR
Dec 1, 2022Grant or award from the company
Employee Stock Option (right to buy)
+26,25026,250 directFiling · EDGAR
All 17 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Aug 12, 2026Form 4Replimune Group REPLFiling · EDGAR
May 20, 2026Form 4Replimune Group REPLFiling · EDGAR
Apr 7, 2026Form 4Replimune Group REPLFiling · EDGAR
Dec 19, 2025Form 4Replimune Group REPLFiling · EDGAR
Nov 19, 2025Form 4Replimune Group REPLFiling · EDGAR
May 22, 2025Form 4Replimune Group REPLFiling · EDGAR
Apr 3, 2025Form 4Replimune Group REPLFiling · EDGAR
Nov 20, 2024Form 4Replimune Group REPLFiling · EDGAR
Jun 10, 2024Form 4Replimune Group REPLFiling · EDGAR
Jun 7, 2024Form 144Replimune Group REPLFiling · EDGAR
May 20, 2024Form 4Replimune Group REPLFiling · EDGAR
Apr 3, 2024Form 4Replimune Group REPLFiling · EDGAR
Nov 17, 2023Form 4Replimune Group REPLFiling · EDGAR
May 18, 2023Form 4Replimune Group REPLFiling · EDGAR
Apr 4, 2023Form 4Replimune Group REPLFiling · EDGAR
Dec 5, 2022Form 4Replimune Group REPLFiling · EDGAR
Dec 5, 2022Form 3Replimune Group REPLFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.